- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: afatinib (BIBW 2992)
Total 2394 results
-
Boehringer IngelheimCompleted
-
Centre Leon BerardBoehringer IngelheimCompletedHead and Neck Squamous Cell CarcinomaFrance
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedGliomaUnited States, Canada
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University College, LondonBoehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Boehringer IngelheimTerminatedNeoplasmsUnited States, Taiwan
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Brazil, Colombia, Peru
-
Medical University of South CarolinaBoehringer IngelheimWithdrawnLung CancerUnited States
-
Universitätsklinikum Hamburg-EppendorfBoehringer IngelheimTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Ureter Cancer | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Stage III Urethral Cancer | Stage IV Urethral CancerUnited States
-
M.D. Anderson Cancer CenterBoehringer IngelheimTerminatedLung CancerUnited States
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungItaly
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungAustralia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsBelgium, Germany
-
Boehringer IngelheimCompletedNeoplasmsUnited Kingdom
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Taiwan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
ETOP IBCSG Partners FoundationCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Instituto Nacional de Cancerologia de MexicoCompletedNon-Small Cell Lung Cancer | EGFR | HER-2Mexico
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHead and Neck Neoplasms | Carcinoma, Squamous CellUnited States, Belgium, France, Spain
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungAustria, Germany, Spain, China, Taiwan, Argentina, Australia, Belgium, Brazil, Finland, France, Hungary, India, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Poland, Russian Federation, Ukraine, United Kingdom
-
Boehringer IngelheimCompletedColorectal NeoplasmsUnited Kingdom
-
National Taiwan University HospitalRecruiting
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Netherlands
-
Boehringer IngelheimCompleted
-
National Cancer Center, KoreaBoehringer IngelheimCompletedNon-small Cell Lung CancerKorea, Republic of
-
Boehringer IngelheimCompleted
-
Columbia UniversityBoehringer IngelheimWithdrawnEsophageal Cancer | Gastrooesophageal Cancer | HER-2 Positive Gastric Cancer
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedAdenocarcinoma | Carcinoma, Non-Small-Cell LungHong Kong, Canada, Korea, Republic of, Belgium, Australia, United States, Taiwan, United Kingdom, Germany, Italy, Japan, Austria, Thailand, Peru, Ireland, Russian Federation, Philippines, France, Brazil, Chile, Argentina, Hungary, M... and more